1
|
Han JH, Jo K. Development of a digital star-shot analysis system for comparing radiation and imaging isocenters of proton treatment machine. J Appl Clin Med Phys 2024; 25:e14320. [PMID: 38454657 PMCID: PMC11087181 DOI: 10.1002/acm2.14320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 01/16/2024] [Accepted: 02/22/2024] [Indexed: 03/09/2024] Open
Abstract
PURPOSE To directly compare the radiation and imaging isocenters of a proton treatment machine, we developed and evaluated a real-time radiation isocenter verification system. METHODS The system consists of a plastic scintillator (PI-200, Mitsubishi Chemical Corporation, Tokyo, Japan), an acrylic phantom, a steel ball on the detachable plate, Raspberry Pi 4 (Raspberry Pi Foundation, London, UK) with camera module, and analysis software implemented through a Python-based graphical user interface (GUI). After kV imaging alignment of the steel ball, the imaging isocenter defined as the position of the steel ball was extracted from the optical image. The proton star-shot was obtained by optical camera because the scintillator converted proton beam into visible light. Then the software computed both the minimum circle radius and the radiation isocenter position from the star-shot. And the deviation between the imaging isocenter and radiation isocenter was calculated. We compared our results with measurements obtained by Gafchromic EBT3 film (Ashland, NJ, USA). RESULTS The minimum circle radii were averaged 0.29 and 0.41 mm while the position deviations from the radiation isocenter to the laser marker were averaged 0.99 and 1.07 mm, for our system and EBT3 film, respectively. Furthermore, the average position difference between the radiation isocenter and imaging isocenter was 0.27 mm for our system. Our system reduced analysis time by 10 min. CONCLUSIONS Our system provided automated star-shot analysis with sufficient accuracy, and it is cost-effective alternative to conventional film-based method for radiation isocenter verification.
Collapse
Affiliation(s)
- Ji Hye Han
- Department of PhysicsEwha Womans UniversitySeoulSouth Korea
| | - Kwanghyun Jo
- Department of Radiation OncologySamsung Medical CenterSeoulSouth Korea
| |
Collapse
|
2
|
Jang YJ, Yang TK, Kim JH, Jang HS, Jeong JH, Kim KB, Kim GB, Park SH, Choi SH. Development of a Real-Time Pixel Array-Type Detector for Ultrahigh Dose-Rate Beams. SENSORS (BASEL, SWITZERLAND) 2023; 23:4596. [PMID: 37430512 DOI: 10.3390/s23104596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 05/08/2023] [Accepted: 05/08/2023] [Indexed: 07/12/2023]
Abstract
Although research into ultrahigh dose-rate (UHDR) radiation therapy is ongoing, there is a significant lack of experimental measurements for two-dimensional (2D) dose-rate distributions. Additionally, conventional pixel-type detectors result in significant beam loss. In this study, we developed a pixel array-type detector with adjustable gaps and a data acquisition system to evaluate its effectiveness in measuring UHDR proton beams in real time. We measured a UHDR beam at the Korea Institute of Radiological and Medical Sciences using an MC-50 cyclotron, which produced a 45-MeV energy beam with a current range of 10-70 nA, to confirm the UHDR beam conditions. To minimize beam loss during measurement, we adjusted the gap and high voltage on the detector and determined the collection efficiency of the developed detector through Monte Carlo simulation and experimental measurements of the 2D dose-rate distribution. We also verified the accuracy of the real-time position measurement using the developed detector with a 226.29-MeV PBS beam at the National Cancer Center of the Republic of Korea. Our results indicate that, for a current of 70 nA with an energy beam of 45 MeV generated using the MC-50 cyclotron, the dose rate exceeded 300 Gy/s at the center of the beam, indicating UHDR conditions. Simulation and experimental measurements show that fixing the gap at 2 mm and the high voltage at 1000 V resulted in a less than 1% loss of collection efficiency when measuring UHDR beams. Furthermore, we achieved real-time measurements of the beam position with an accuracy of within 2% at five reference points. In conclusion, our study developed a beam monitoring system that can measure UHDR proton beams and confirmed the accuracy of the beam position and profile through real-time data transmission.
Collapse
Affiliation(s)
- Young Jae Jang
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
- Department of Accelerator Science, Korea University, Sejong 30015, Republic of Korea
| | - Tae Keun Yang
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| | - Jeong Hwan Kim
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| | - Hong Suk Jang
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| | - Jong Hwi Jeong
- Center for ProtonTherapy, National Cancer Center, Goyang 10408, Republic of Korea
| | - Kum Bae Kim
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| | - Geun-Beom Kim
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| | - Seong Hee Park
- Department of Accelerator Science, Korea University, Sejong 30015, Republic of Korea
| | - Sang Hyoun Choi
- Research Team of Radiological Physics & Engineering, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea
| |
Collapse
|
3
|
Guo Y, Li B, Li Y, Du W, Feng W, Feng S, Miao G. Application of a linear interpolation algorithm in radiation therapy dosimetry for 3D dose point acquisition. Sci Rep 2023; 13:4539. [PMID: 36941321 PMCID: PMC10027884 DOI: 10.1038/s41598-023-31562-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 03/14/2023] [Indexed: 03/23/2023] Open
Abstract
Air-vented ion chambers are generally used in radiation therapy dosimetry to determine the absorbed radiation dose with superior precision. However, in ion chamber detector arrays, the number of array elements and their spacing do not provide sufficient spatial sampling, which can be overcome by interpolating measured data. Herein, we investigated the potential principle of the linear interpolation algorithm in volumetric dose reconstruction based on computed tomography images in the volumetric modulated arc therapy (VMAT) technique and evaluated how the ion chamber spacing and anatomical mass density affect the accuracy of interpolating new data points. Plane measurement doses on 83 VMAT treatment plans at different anatomical sites were acquired using Octavius 729, Octavius1500, and MatriXX ion chamber detector arrays, followed by the linear interpolation to reconstruct volumetric doses. Dosimetric differences in planning target volumes (PTVs) and organs at risk (OARs) between treatment planning system and reconstruction were evaluated by dose volume histogram metrics. The average percentage dose deviations in the mean dose (Dmean) of PTVs reconstructed by 729 and 1500 arrays ranged from 4.7 to 7.3% and from 1.5 to 2.3%, while the maximum dose (Dmax) counterparts ranged from 2.3 to 5.5% and from 1.6 to 7.6%, respectively. The average percentage dose/volume deviations of mixed PTVs and OARs in the abdomen/gastric and pelvic sites were 7.6%, 3.5%, and 7.2%, while mediastinum and lung plans showed slightly larger values of 8.7%, 5.1%, and 8.9% for 729, 1500, and MatriXX detector arrays, respectively. Our findings indicated that the smaller the spacing between neighbouring detectors and the more ion chambers present, the smaller the error in interpolating new data points. Anatomical regions with small local mass density inhomogeneity were associated with superior dose reconstruction. Given a large mass density difference in the various human anatomical structures and the characteristics of the linear interpolation algorithm, we suggest that an alternative data interpolation method should be used in radiotherapy dosimetry.
Collapse
Affiliation(s)
- Yixiao Guo
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Bo Li
- Department of Bone and Soft-Tissue Carcinoma, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Yazhou Li
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Wen Du
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Weigui Feng
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Shifang Feng
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China
| | - Guoying Miao
- Department of Radiation Oncology, Gansu Provincial Hospital, Lanzhou, 730000, People's Republic of China.
| |
Collapse
|
4
|
Cheon W, Jung H, Lee M, Lee J, Kim SJ, Cho S, Han Y. Development of a time-resolved mirrorless scintillation detector. PLoS One 2021; 16:e0246742. [PMID: 33577602 PMCID: PMC7880495 DOI: 10.1371/journal.pone.0246742] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Accepted: 01/25/2021] [Indexed: 11/28/2022] Open
Abstract
Purpose We developed a compact and lightweight time-resolved mirrorless scintillation detector (TRMLSD) employing image processing techniques and a convolutional neural network (CNN) for high-resolution two-dimensional (2D) dosimetry. Methods The TRMLSD comprises a camera and an inorganic scintillator plate without a mirror. The camera was installed at a certain angle from the horizontal plane to collect scintillation from the scintillator plate. The geometric distortion due to the absence of a mirror and camera lens was corrected using a projective transform. Variations in brightness due to the distance between the image sensor and each point on the scintillator plate and the inhomogeneity of the material constituting the scintillator were corrected using a 20.0 × 20.0 cm2 radiation field. Hot pixels were removed using a frame-based noise-reduction technique. Finally, a CNN-based 2D dose distribution deconvolution model was applied to compensate for the dose error in the penumbra region and a lack of backscatter. The linearity, reproducibility, dose rate dependency, and dose profile were tested for a 6 MV X-ray beam to verify dosimeter characteristics. Gamma analysis was performed for two simple and 10 clinical intensity-modulated radiation therapy (IMRT) plans. Results The dose linearity with brightness ranging from 0.0 cGy to 200.0 cGy was 0.9998 (R-squared value), and the root-mean-square error value was 1.010. For five consecutive measurements, the reproducibility was within 3% error, and the dose rate dependency was within 1%. The depth dose distribution and lateral dose profile coincided with the ionization chamber data with a 1% mean error. In 2D dosimetry for IMRT plans, the mean gamma passing rates with a 3%/3 mm gamma criterion for the two simple and ten clinical IMRT plans were 96.77% and 95.75%, respectively. Conclusion The verified accuracy and time-resolved characteristics of the dosimeter may be useful for the quality assurance of machines and patient-specific quality assurance for clinical step-and-shoot IMRT plans.
Collapse
Affiliation(s)
- Wonjoong Cheon
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Hyunuk Jung
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Moonhee Lee
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
| | - Jinhyeop Lee
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
| | - Sung Jin Kim
- Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea
| | - Sungkoo Cho
- Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea
| | - Youngyih Han
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- * E-mail:
| |
Collapse
|
5
|
Brodbek L, Kretschmer J, Willborn K, Meijers A, Both S, Langendijk JA, Knopf AC, Looe HK, Poppe B. Analysis of the applicability of two-dimensional detector arrays in terms of sampling rate and detector size to verify scanned intensity-modulated proton therapy plans. Med Phys 2020; 47:4589-4601. [PMID: 32574383 DOI: 10.1002/mp.14346] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 06/10/2020] [Accepted: 06/11/2020] [Indexed: 11/05/2022] Open
Abstract
PURPOSE The introduction of advanced treatment techniques in proton therapy, such as intensity-modulated proton therapy, leads to an increased need for patient-specific quality assurance, especially an accurate treatment plan verification becomes inevitable. In this study, signal theoretical analysis of dose distributions in scanned proton therapy is performed to investigate the feasibility and limits of two-dimensional (2D) detector arrays for treatment plan verification. METHODS 2D detector arrays are characterized by two main aspects: the distance between the single detectors on the array or the sampling frequency; and the lateral response functions of a single detector. The analysis is based on single spots, reference fields and on measured and calculated dose distributions of typical intensity-modulated proton therapy treatment plans with and without range shifter. Measurements were performed with Gafchromic EBT3 films (Ashland Speciality Ingredients G.P., Bridgewater, NJ, USA), the MatriXX PT detector array (IBA Dosimetry, Schwarzenbruck, Germany) and the OCTAVIUS detector array 1500XDR (PTW-Freiburg, Germany) at an IBA Proteus PLUS proton therapy system (Ion Beam Applications, Louvain-la-Neuve, Belgium). Dose calculations were performed with the treatment planning system RayStation 6 or 8 (RaySearch Laboratories, Sweden). RESULTS The Fourier analysis of the data of the treatment planning system and film measurements show maximum frequencies of 0.06/mm for the plan with range shifter and 0.083/mm for the plan without range shifter. According to the Nyquist theorem, this corresponds to minimum required sampling distances of 8.3 and 6 mm, respectively. By comparison, the sampling distances of the arrays of 7.6 mm (MatriXX PT) and 7.1 mm (OD1500XDR) are sufficient to reconstruct the dose distributions adequately from measurements if range shifters are used, whereas some fields of the plans without range shifter violated the Nyquist requirement. The lateral dose response functions of the single detectors within the arrays have clearly higher frequencies than the treatment plans and thus the volume effect only slightly influences the measurements. Consequently, the array measurements show high gamma passing rates with at least 96 % and a good agreement between the investigated line profiles. CONCLUSION The results indicate that the detector dimensions and sampling distances of the arrays are in most studied cases adequate not to substantially influence the measurement process when they are used for analyzing typical intensity-modulated proton therapy treatment plans. Nevertheless, clinical conditions have been identified, for instance treatment plans without range shifter, under which the Nyquist theorem is violated such that a full representation of the dose distributions with the measurements is not feasible. In these cases, analysis of measurements is limited to pointwise comparisons.
Collapse
Affiliation(s)
- Leonie Brodbek
- University Clinic for Medical Radiation Physics, Medical Campus Pius Hospital, Carl-von-Ossietzky University, Oldenburg, Germany.,Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Jana Kretschmer
- University Clinic for Medical Radiation Physics, Medical Campus Pius Hospital, Carl-von-Ossietzky University, Oldenburg, Germany
| | - Kay Willborn
- University Clinic for Medical Radiation Physics, Medical Campus Pius Hospital, Carl-von-Ossietzky University, Oldenburg, Germany
| | - Arturs Meijers
- Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Stefan Both
- Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Johannes A Langendijk
- Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Antje-Christin Knopf
- Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Hui Khee Looe
- University Clinic for Medical Radiation Physics, Medical Campus Pius Hospital, Carl-von-Ossietzky University, Oldenburg, Germany
| | - Björn Poppe
- University Clinic for Medical Radiation Physics, Medical Campus Pius Hospital, Carl-von-Ossietzky University, Oldenburg, Germany
| |
Collapse
|
6
|
Selection of gamma analysis acceptance criteria in IMRT QA using Gafchromic EBT3 film dosimetry. JOURNAL OF RADIOTHERAPY IN PRACTICE 2019. [DOI: 10.1017/s1460396918000602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractBackground and purposeThis study reported the justification and selection of acceptable γ criteria with respect to low (6 MV) and high (15 MV) photon beams for intensity-modulated radiation therapy quality assurance (IMRT QA) using the Gafchromic external beam therapy 3 (EBT3) film.Materials and methodsFive-field step-and-shoot IMRT was used to treat 16 brain IMRT patients using the dual-energy DHX-S linear accelerator (Varian Medical System, Palo Alto, CA, USA). Dose comparisons between computed values of the treatment planning system (TPS) and Gafchromic EBT3 film were evaluated based on γ analysis using the Film QA Pro software. The dose distribution was analysed with gamma area histograms (GAHs) generated using different γ criteria (3%/2 mm, 3%/3 mm and 5%/3 mm) for the 6 and 15 MV photon beams, to optimise the best distance-to-agreement (DTA) criteria with respect to the beam energy.ResultsFrom the comparison between the dose distributions acquired from the TPS and EBT3 film, a DTA criterion of 3%/2 mm showed less dose differences (DDs) with passing rates up to 93% for the 6 MV photon beams, while for the 15 MV a relaxed DTA criterion of 5%/3 mm was consistent with the DD acceptability criteria with a 95% passing rate.ConclusionsOur results suggested that high-energy photon beams required relaxed DTA criteria for the brain IMRT QA, while low-energy photon beams showed better results even with tight DTA criteria.
Collapse
|
7
|
Quality assurance of linear accelerator: a comprehensive system using electronic portal imaging device. JOURNAL OF RADIOTHERAPY IN PRACTICE 2019. [DOI: 10.1017/s146039691800050x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
AbstractAimThe Electronic Portal Imaging Device (EPID), primarily used for patient setup during radiotherapy sessions is also used for dosimetric measurements. In the present study, the feasibility of EPID in both machine and patient-specific quality assurance (QA) are investigated. We have developed a comprehensive software tool for effective utilisation of EPID in our institutional QA protocol.Materials and methodsPortal Vision aS1000, amorphous silicon portal detector attached to Clinac iX—Linear Accelerator (LINAC) was used to measure daily profile and output constancy, various Multi-Leaf Collimator (MLC) checks and patient plan verification. Different QA plans were generated with the help of Eclipse Treatment Planning System (TPS) and MLC shaper software. The indigenously developed MATLAB programs were used for image analysis. Flatness, symmetry, output constancy, Field Width at Half Maximum (FWHM) and fluence comparison were studied from images obtained from TPS and EPID dosimetry.ResultsThe 3 years institutional data of profile constancy and patient-specific QA measured using EPID were found within the acceptable limits. The daily output of photon beam correlated with the output obtained through solid phantom measurements. The Pearson correlation coefficients are 0.941 (p = 0.0001), 0.888 (p = 0.0188) and 0.917 (p = 0.0007) for the years of 2014, 2015 and 2016, respectively. The accuracy of MLC for shaping complex treatment fields was studied in terms of FWHM at different portions of various fields, showed good agreement between TPS-generated and EPID-measured MLC positions. The comparison of selected patient plans in EPID with an independent 2D array detector system showed statistically significant correlation between these two systems. Percentage difference between TPS computed and EPID measured fluence maps calculated for number of patients using MATLAB code also exhibited the validity of those plans for treatment.
Collapse
|
8
|
Patient-specific quality control for intensity-modulated radiation therapy and volumetric-modulated arc therapy using electronic portal imaging device and two-dimensional ion chamber array. JOURNAL OF RADIOTHERAPY IN PRACTICE 2019. [DOI: 10.1017/s1460396918000328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractAimThe purpose of this study was to develop the patient-specific quality control (QC) process by most commonly used dosimeters in Bangladesh and recommend a suitable passing rate for QC, irrespective of the dosimetric tools used.Materials and methodsIntensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) plans of five head-and-neck (HN) and five prostate patients were selected for the patient-specific QC. These plans were generated using the Eclipse TPS v11·0 (Varian Medical Systems, Inc., Palo Alto, CA, USA) 6 MV X-ray from a Varian TrueBeam linear accelerator (Varian Medical Systems, Inc.) for each case. Each IMRT and VMAT plans were measured by two-dimensional (2D) ion chamber arrays (I’matriXX) and electronic portal imaging devices (EPID), respectively. The passing rates of the dosimetric tools were calculated using criteria of 3%/3 mm.ResultsThe average passing rates (±SD) of I’matriXX for prostate and HN were 97·9±0·76 and 98·88±0·24, respectively. For VMAT verification, the average passing rates of EPID for prostate for arc1 and arc2 were 96·15±0·49 and 97·8±0·70, respectively; similarly, for HN the rates were 97·85±0·63 and 97·2±0·56, respectively.ConclusionThe results showed that both the dosimeters can be used in patient-specific QC, although the EPID-based IMRT and VMAT QC is more advantageous in terms of time-saving and ease of use. Hence, for patient-specific QC, one can use the ion chamber arrays (I’matriXX) or EPID in hospital, but the systems need to be cross-checked.
Collapse
|
9
|
Commissioning and evaluation of a radiochromic EBT3 film dosimetry system. JOURNAL OF RADIOTHERAPY IN PRACTICE 2018. [DOI: 10.1017/s1460396918000444] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
AbstractPurposeThis work reports our study to commission a radiochromic film dosimetry system using the timely EBT3 film. We carried out dosimetric evaluations on different characteristics of photon beams (e.g., flatness, symmetry and penumbra) in radiation dose delivery.Materials and MethodsA Varian linear accelerator producing 6 and 15 MV photon beams with 120 multi-leaf collimator was used in this study. PTW ionisation chamber was used to measure the beam characteristics such as symmetry, flatness and penumbra and these measurements were used to commission the radiochormic EBT3 film dosimetry system. The results of irradiated films were analysed using the radiochromic film QA Pro software 2016.ResultsThe measured film doses were analysed at two different colour channels (green and red) using two scanning geometries (i.e., upper or lower side of film facing the scanner light source) at two dose levels (10 and 40 Gy). The difference between the ionisation chamber and film results was found insignificant and within the acceptable range as per the World Health Organisation standard.ConclusionResults of the comparison between the ionisation chamber and film measurements show that our radiochormic EBT3 film dosimetry system is reliable and cost-effective in the output measurement of a linear accelerator. Our measurements confirm that our EBT3 film dosimetry agreed well with the ionisation chamber, and can be used as a re-validation tool for linear accelerator quality control.
Collapse
|
10
|
Sekar Y, Thoelking J, Eckl M, Kalichava I, Sihono DSK, Lohr F, Wenz F, Wertz H. Characterization and clinical evaluation of a novel 2D detector array for conventional and flattening filter free (FFF) IMRT pre-treatment verification. Z Med Phys 2018; 28:134-141. [DOI: 10.1016/j.zemedi.2017.08.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2017] [Revised: 07/12/2017] [Accepted: 08/28/2017] [Indexed: 12/01/2022]
|
11
|
Zhang Y, Brandner E, Ozhasoglu C, Lalonde R, Heron DE, Huq MS. A 3D correction method for predicting the readings of a PinPoint chamber on the CyberKnife ® M6 ™ machine. Phys Med Biol 2018; 63:045010. [PMID: 29350197 DOI: 10.1088/1361-6560/aaa90d] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The use of small fields in radiation therapy techniques has increased substantially in particular in stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). However, as field size reduces further still, the response of the detector changes more rapidly with field size, and the effects of measurement uncertainties become increasingly significant due to the lack of lateral charged particle equilibrium, spectral changes as a function of field size, detector choice, and subsequent perturbations of the charged particle fluence. This work presents a novel 3D dose volume-to-point correction method to predict the readings of a 0.015 cc PinPoint chamber (PTW 31014) for both small static-fields and composite-field dosimetry formed by fixed cones on the CyberKnife® M6™ machine. A 3D correction matrix is introduced to link the 3D dose distribution to the response of the PinPoint chamber in water. The parameters of the correction matrix are determined by modeling its 3D dose response in circular fields created using the 12 fixed cones (5 mm-60 mm) on a CyberKnife® M6™ machine. A penalized least-square optimization problem is defined by fitting the calculated detector reading to the experimental measurement data to generate the optimal correction matrix; the simulated annealing algorithm is used to solve the inverse optimization problem. All the experimental measurements are acquired for every 2 mm chamber shift in the horizontal planes for each field size. The 3D dose distributions for the measurements are calculated using the Monte Carlo calculation with the MultiPlan® treatment planning system (Accuray Inc., Sunnyvale, CA, USA). The performance evaluation of the 3D conversion matrix is carried out by comparing the predictions of the output factors (OFs), off-axis ratios (OARs) and percentage depth dose (PDD) data to the experimental measurement data. The discrepancy of the measurement and the prediction data for composite fields is also performed for clinical SRS plans. The optimization algorithm used for generating the optimal correction factors is stable, and the resulting correction factors were smooth in the spatial domain. The measurement and prediction of OFs agree closely with percentage differences of less than 1.9% for all the 12 cones. The discrepancies between the prediction and the measurement PDD readings at 50 mm and 80 mm depth are 1.7% and 1.9%, respectively. The percentage differences of OARs between measurement and prediction data are less than 2% in the low dose gradient region, and 2%/1 mm discrepancies are observed within the high dose gradient regions. The differences between the measurement and prediction data for all the CyberKnife based SRS plans are less than 1%. These results demonstrate the existence and efficiency of the novel 3D correction method for small field dosimetry. The 3D correction matrix links the 3D dose distribution and the reading of the PinPoint chamber. The comparison between the predicted reading and the measurement data for static small fields (OFs, OARs and PDDs) yield discrepancies within 2% for low dose gradient regions and 2%/1 mm for high dose gradient regions; the discrepancies between the predicted and the measurement data are less than 1% for all the SRS plans. The 3D correction method provides an access to evaluate the clinical measurement data and can be applied to non-standard composite fields intensity modulated radiation therapy point dose verification.
Collapse
|
12
|
A method to enhance 2D ion chamber array patient specific quality assurance for IMRT. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE 2016; 40:145-151. [PMID: 27873283 DOI: 10.1007/s13246-016-0498-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2015] [Accepted: 11/04/2016] [Indexed: 10/20/2022]
Abstract
Gamma index comparison has been established as a method for patient specific quality assurance in IMRT. Detector arrays can replace radiographic film systems to record 2D dose distributions and fulfill quality assurance requirements. These electronic devices present spatial resolution disadvantages with respect to films. This handicap can be partially overcome with a multiple acquisition sequence of adjacent 2D dose distributions. The detector spatial response influence can also be taken into account through the convolution of the calculated dose with the detector spatial response. A methodology that employs both approaches could allow for enhancements of the quality assurance procedure. 35 beams from different step and shoot IMRT plans were delivered on a phantom. 2D dose distributions were recorded with a PTW-729 ion chamber array for individual beams, following the multiple acquisition methodology. 2D dose distributions were also recorded on radiographic films. Measured dose distributions with films and with the PTW-729 array were processed with the software RITv5.2 for Gamma index comparison with calculated doses. Calculated dose was also convolved with the ion chamber 2D response and the Gamma index comparisons with the 2D dose distribution measured with the PTW-729 array was repeated. 3.7 ± 2.7% of points surpassed the accepted Gamma index when using radiographic films compared with calculated dose, with a minimum of 0.67 and a maximum of 13.27. With the PTW-729 multiple acquisition methodology compared with calculated dose, 4.1 ± 1.3% of points surpassed the accepted Gamma index, with a minimum of 1.44 and a maximum of 11.26. With the PTW- multiple acquisition methodology compared with convolved calculated dose, 2.7 ± 1.3% of points surpassed the accepted Gamma index, with a minimum of 0.42 and a maximum of 5.75. The results obtained in this work suggest that the comparison of merged adjacent dose distributions with convolved calculated dose represents an enhancement in the methodology for IMRT patient specific quality assurance with the PTW-729 ion chamber array.
Collapse
|
13
|
Thoelking J, Fleckenstein J, Sekar Y, Boggula R, Lohr F, Wenz F, Wertz H. Patient-specific online dose verification based on transmission detector measurements. Radiother Oncol 2016; 119:351-6. [DOI: 10.1016/j.radonc.2016.04.003] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2015] [Revised: 03/23/2016] [Accepted: 04/02/2016] [Indexed: 11/29/2022]
|
14
|
Kadam A, Sharma S. Estimation of local confidence limit for 6 MV photon beam IMRT system using AAPM TG 119 test protocol. INTERNATIONAL JOURNAL OF CANCER THERAPY AND ONCOLOGY 2016. [DOI: 10.14319/ijcto.41.10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
15
|
Son J, Baek T, Lee B, Shin D, Park SY, Park J, Lim YK, Lee SB, Kim J, Yoon M. A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy. Radiol Oncol 2015; 49:307-13. [PMID: 26401138 PMCID: PMC4577229 DOI: 10.1515/raon-2015-0021] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Accepted: 01/18/2015] [Indexed: 11/23/2022] Open
Abstract
Background This study was designed to compare the quality assurance (QA) results of four dosimetric tools used for intensity modulated radiation therapy (IMRT) and to suggest universal criteria for the passing rate in QA, irrespective of the dosimetric tool used. Materials and methods. Thirty fields of IMRT plans from five patients were selected, followed by irradiation onto radiochromic film, a diode array (Mapcheck), an ion chamber array (MatriXX) and an electronic portal imaging device (EPID) for patient-specific QA. The measured doses from the four dosimetric tools were compared with the dose calculated by the treatment planning system. The passing rates of the four dosimetric tools were calculated using the gamma index method, using as criteria a dose difference of 3% and a distance-to-agreement of 3 mm. Results The QA results based on Mapcheck, MatriXX and EPID showed good agreement, with average passing rates of 99.61%, 99.04% and 99.29%, respectively. However, the average passing rate based on film measurement was significantly lower, 95.88%. The average uncertainty (1 standard deviation) of passing rates for 6 intensity modulated fields was around 0.31 for film measurement, larger than those of the other three dosimetric tools. Conclusions QA results and consistencies depend on the choice of dosimetric tool. Universal passing rates should depend on the normalization or inter-comparisons of dosimetric tools if more than one dosimetric tool is used for patient specific QA.
Collapse
Affiliation(s)
- Jaeman Son
- Department of Bio-Convergence Engineering, Korea University, Seoul, Korea ; Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Taesung Baek
- Department of Bio-Convergence Engineering, Korea University, Seoul, Korea ; Department of Radiation Oncology, Ilsan Hospital, Goyang, Korea
| | - Boram Lee
- Department of Bio-Convergence Engineering, Korea University, Seoul, Korea ; Department of Radiation Oncology, Sun Hospital, Daejeon, Korea
| | - Dongho Shin
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Sung Yong Park
- McLaren Proton Therapy Center, Karmanos Cancer Institute, Flint, MI, USA
| | - Jeonghoon Park
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Young Kyung Lim
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Se Byeong Lee
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Jooyoung Kim
- Proton Therapy Center, National Cancer Center, Goyang, Korea
| | - Myonggeun Yoon
- Department of Bio-Convergence Engineering, Korea University, Seoul, Korea
| |
Collapse
|
16
|
Deshpande S, McNamara AL, Holloway L, Metcalfe P, Vial P. Feasibility study of a dual detector configuration concept for simultaneous megavoltage imaging and dose verification in radiotherapy. Med Phys 2015; 42:1753-64. [DOI: 10.1118/1.4907966] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
|
17
|
Ritter TA, Gallagher I, Roberson PL. Using a 2D detector array for meaningful and efficient linear accelerator beam property validations. J Appl Clin Med Phys 2014; 15:4749. [PMID: 25493506 PMCID: PMC5711127 DOI: 10.1120/jacmp.v15i6.4749] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2013] [Revised: 08/05/2014] [Accepted: 07/29/2014] [Indexed: 11/23/2022] Open
Abstract
Following linear accelerator commissioning, the qualified medical physicist is responsible for monitoring the machine's ongoing performance, detecting and investigating any changes in beam properties, and assessing the impact of unscheduled repairs. In support of these responsibilities, the authors developed a method of using a 2D ionization chamber array to efficiently test and validate important linear accelerator photon beam properties. A team of three physicists identified critical properties of the accelerator and developed constancy tests that were sensitive to each of the properties. The result was a 14‐field test plan. The test plan includes large and small fields at varying depths, a reduced SSD field at shallow depth for sensitivity to extra focal photon and electron components, and analysis of flatness, symmetry, dose, dose profiles, and dose ratios. Constancy tests were repeated five times over a period of six weeks and used to set upper and lower investigation levels at ±3 SDs. Deliberate variations in output, penumbra, and energy were tested to determine the suitability of the proposed method. Measurements were also performed on a similar, but distinct, machine to assess test sensitivity. The results demonstrated upper and lower investigation levels significantly smaller than the comparable TG‐142 annual recommendations, with the exception of the surrogate used for output calibration, which still fell within the TG‐142 monthly recommendation. Subtle changes in output, beam energy, and penumbra were swiftly identified for further investigation. The test set identified the distinct nature of the second accelerator. The beam properties of two photon energies can be validated in approximately 1.5 hrs using this method. The test suite can be used to evaluate the impact of minor repairs, detect changes in machine performance over time, and supplement other machine quality assurance testing. PACS numbers: 87.56bd, 87.56Fc
Collapse
Affiliation(s)
- Timothy A Ritter
- University of Michigan, Veterans Affairs Ann Arbor Health Care System.
| | | | | |
Collapse
|
18
|
Elawady R, Attalla E, Elshemey W, Shouman T, Alsayed A. Dose verification of intensity modulated radiotherapy in head and neck tumors. INTERNATIONAL JOURNAL OF CANCER THERAPY AND ONCOLOGY 2014. [DOI: 10.14319/ijcto.0203.7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
19
|
Townson RW, Zavgorodni S. Pre-treatment radiotherapy dose verification using Monte Carlo doselet modulation in a spherical phantom. Phys Med Biol 2014; 59:1923-34. [DOI: 10.1088/0031-9155/59/8/1923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
20
|
Vikraman S, Manigandan D, Karrthick KP, Sambasivaselli R, Senniandavar V, Ramu M, Rajesh T, Lutz M, Muthukumaran M, Karthikeyan N, Tejinder K. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS. J Appl Clin Med Phys 2014; 16:5128. [PMID: 25679152 PMCID: PMC5689974 DOI: 10.1120/jacmp.v16i1.5128] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Revised: 10/14/2014] [Accepted: 10/06/2014] [Indexed: 11/28/2022] Open
Abstract
The purpose of this study was to evaluate quantitatively the patient‐specific 3D dosimetry tool COMPASS with 2D array MatriXX detector for stereotactic volumetric‐modulated arc delivery. Twenty‐five patients CT images and RT structures from different sites (brain, head & neck, thorax, abdomen, and spine) were taken from CyberKnife Multiplan planning system for this study. All these patients underwent radical stereotactic treatment in CyberKnife. For each patient, linac based volumetric‐modulated arc therapy (VMAT) stereotactic plans were generated in Monaco TPS v3.1 using Elekta Beam Modulator MLC. Dose prescription was in the range of 5–20 Gy per fraction. Target prescription and critical organ constraints were tried to match the delivered treatment plans. Each plan quality was analyzed using conformity index (CI), conformity number (CN), gradient Index (GI), target coverage (TC), and dose to 95% of volume (D95). Monaco Monte Carlo (MC)‐calculated treatment plan delivery accuracy was quantitatively evaluated with COMPASS‐calculated (CCA) dose and COMPASS indirectly measured (CME) dose based on dose‐volume histogram metrics. In order to ascertain the potential of COMPASS 3D dosimetry for stereotactic plan delivery, 2D fluence verification was performed with MatriXX using MultiCube phantom. Routine quality assurance of absolute point dose verification was performed to check the overall delivery accuracy. Quantitative analyses of dose delivery verification were compared with pass and fail criteria of 3 mm and 3% distance to agreement and dose differences. Gamma passing rate was compared with 2D fluence verification from MatriXX with MultiCube. Comparison of COMPASS reconstructed dose from measured fluence and COMPASS computed dose has shown a very good agreement with TPS calculated dose. Each plan was evaluated based on dose volume parameters for target volumes such as dose at 95% of volume (D95) and average dose. For critical organs dose at 20% of volume (D20), dose at 50% of volume (D50), and maximum point doses were evaluated. Comparison was carried out using gamma analysis with passing criteria of 3 mm and 3%. Mean deviation of 1.9%±1% was observed for dose at 95% of volume (D95) of target volumes, whereas much less difference was noticed for critical organs. However, significant dose difference was noticed in two cases due to the smaller tumor size. Evaluation of this study revealed that the COMPASS 3D dosimetry is efficient and easy to use for patient‐specific QA of VMAT stereotactic delivery. 3D dosimetric QA with COMPASS provides additional degrees of freedom to check the high‐dose modulated stereotactic delivery with very high precision on patient CT images. PACS numbers: 87.55.Qr, 87.56.Fc
Collapse
|
21
|
Aitkenhead AH, Rowbottom CG, Mackay RI. Marvin: an anatomical phantom for dosimetric evaluation of complex radiotherapy of the head and neck. Phys Med Biol 2013; 58:6915-29. [PMID: 24029583 DOI: 10.1088/0031-9155/58/19/6915] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
22
|
Sabet M, Rowshanfarzad P, Vial P, Menk FW, Greer PB. Transit dosimetry in IMRT with an a-Si EPID in direct detection configuration. Phys Med Biol 2012; 57:N295-306. [PMID: 22801089 DOI: 10.1088/0031-9155/57/15/n295] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In this study an amorphous silicon electronic portal imaging device (a-Si EPID) converted to direct detection configuration was investigated as a transit dosimeter for intensity modulated radiation therapy (IMRT). After calibration to dose and correction for a background offset signal, the EPID-measured absolute IMRT transit doses for 29 fields were compared to a MatriXX two-dimensional array of ionization chambers (as reference) using Gamma evaluation (3%, 3 mm). The MatriXX was first evaluated as reference for transit dosimetry. The accuracy of EPID measurements was also investigated by comparison of point dose measurements by an ionization chamber on the central axis with slab and anthropomorphic phantoms in a range of simple to complex fields. The uncertainty in ionization chamber measurements in IMRT fields was also investigated by its displacement from the central axis and comparison with the central axis measurements. Comparison of the absolute doses measured by the EPID and MatriXX with slab phantoms in IMRT fields showed that on average 96.4% and 97.5% of points had a Gamma index<1 in head and neck and prostate fields, respectively. For absolute dose comparisons with anthropomorphic phantoms, the values changed to an average of 93.6%, 93.7% and 94.4% of points with Gamma index<1 in head and neck, brain and prostate fields, respectively. Point doses measured by the EPID and ionization chamber were within 3% difference for all conditions. The deviations introduced in the response of the ionization chamber in IMRT fields were<1%. The direct EPID performance for transit dosimetry showed that it has the potential to perform accurate, efficient and comprehensive in vivo dosimetry for IMRT.
Collapse
Affiliation(s)
- Mahsheed Sabet
- School of Mathematical and Physical Sciences, Faculty of Science and IT, University of Newcastle, Callaghan Campus, Newcastle, NSW 2308, Australia.
| | | | | | | | | |
Collapse
|
23
|
Yewondwossen M. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance. Med Dosim 2011; 37:250-6. [PMID: 22189031 DOI: 10.1016/j.meddos.2011.09.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2011] [Revised: 09/12/2011] [Accepted: 09/13/2011] [Indexed: 11/30/2022]
Abstract
The two-dimensional (2D) ionization chamber array MatriXX Evolution is one of the 2D ionization chamber arrays developed by IBA Dosimetry (IBA Dosimetry, Germany) for megavoltage real-time absolute 2D dosimetry and verification of intensity-modulated radiation therapy (IMRT). The purpose of this study was to (1) evaluate the performance of ion chamber array for submegavoltage range brachytherapy beam dose verification and quality assurance (QA) and (2) use the end-to-end dosimetric evaluation that mimics a patient treatment procedure and confirm the primary source strength calibration agrees in both the treatment planning system (TPS) and treatment delivery console computers. The dose linearity and energy dependence of the 2D ion chamber array was studied using kilovoltage X-ray beams (100, 180 and 300 kVp). The detector calibration factor was determined using 300 kVp X-ray beams so that we can use the same calibration factor for dosimetric verification of high-dose-rate (HDR) brachytherapy. The phantom used for this measurement consists of multiple catheters, the IBA MatriXX detector, and water-equivalent slab of RW3 to provide full scattering conditions. The treatment planning system (TPS) (Oncentra brachy version 3.3, Nucletron BV, Veenendaal, the Netherlands) dose distribution was calculated on the computed tomography (CT) scan of this phantom. The measured and TPS calculated distributions were compared in IBA Dosimetry OmniPro-I'mRT software. The quality of agreement was quantified by the gamma (γ) index (with 3% delta dose and distance criterion of 2 mm) for 9 sets of plans. Using a dedicated phantom capable of receiving 5 brachytherapy intralumenal catheters a QA procedure was developed for end-to-end dosimetric evaluation for routine QA checks. The 2D ion chamber array dose dependence was found to be linear for 100-300 kVp and the detector response (k(user)) showed strong energy dependence for 100-300 kVp energy range. For the Ir-192 brachytherapy HDR source, dosimetric evaluation k(user) factor determined by photon beam of energy of 300 kVp was used. The maximum mean difference between ion chamber array measured and TPS calculated was 3.7%. Comparisons of dose distribution for different test plans have shown agreement with >94.5% for γ ≤1. Dosimetric QA can be performed with the 2D ion chamber array to confirm primary source strength calibration is properly updated in both the TPS and treatment delivery console computers. The MatriXX Evolution ionization chamber array has been found to be reliable for measurement of both absolute dose and relative dose distributions for the Ir-192 brachytherapy HDR source.
Collapse
Affiliation(s)
- Mammo Yewondwossen
- Department of Radiation Oncology, Dalhousie University, Halifax, Nova Scotia, Canada.
| |
Collapse
|
24
|
Chung H, Li J, Samant S. Feasibility of using two-dimensional array dosimeter for in vivo dose reconstruction via transit dosimetry. J Appl Clin Med Phys 2011; 12:3370. [PMID: 21844846 PMCID: PMC5718653 DOI: 10.1120/jacmp.v12i3.3370] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2010] [Revised: 02/02/2011] [Accepted: 01/25/2011] [Indexed: 11/23/2022] Open
Abstract
Two-dimensional array dosimeters are commonly used to perform pretreatment quality assurance procedures, which makes them highly desirable for measuring transit fluences for in vivo dose reconstruction. The purpose of this study was to determine if an in vivo dose reconstruction via transit dosimetry using a 2D array dosimeter was possible. To test the accuracy of measuring transit dose distribution using a 2D array dosimeter, we evaluated it against the measurements made using ionization chamber and radiochromic film (RCF) profiles for various air gap distances (distance from the exit side of the solid water slabs to the detector distance; 0 cm, 30 cm, 40 cm, 50 cm, and 60 cm) and solid water slab thicknesses (10 cm and 20 cm). The backprojection dose reconstruction algorithm was described and evaluated. The agreement between the ionization chamber and RCF profiles for the transit dose distribution measurements ranged from -0.2% ~ 4.0% (average 1.79%). Using the backprojection dose reconstruction algorithm, we found that, of the six conformal fields, four had a 100% gamma index passing rate (3%/3 mm gamma index criteria), and two had gamma index passing rates of 99.4% and 99.6%. Of the five IMRT fields, three had a 100% gamma index passing rate, and two had gamma index passing rates of 99.6% and 98.8%. It was found that a 2D array dosimeter could be used for backprojection dose reconstruction for in vivo dosimetry.
Collapse
Affiliation(s)
- Heeteak Chung
- Department of Nuclear and Radiological Engineering, University of Florida, Gainesville, FL, USA.
| | | | | |
Collapse
|
25
|
Saminathan S, Manickam R, Chandraraj V. Plan evaluation and dosimetric comparison of IMRT using AAPM TG119 test suites and recommendations. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE 2011; 34:55-61. [PMID: 21331465 DOI: 10.1007/s13246-011-0058-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2010] [Accepted: 02/04/2011] [Indexed: 10/18/2022]
Abstract
In order to verify intensity modulated radiotherapy quality assurance procedure and to establish the practical base line commissioning, American Association of Physicists in Medicine-Task Group 119 test suite DICOM-RT images and structure were downloaded for planning and dosimetric comparison. The square slab phantom of water equivalent plastic was used for the measurement. This phantom can permit point dose measurement with ionization chamber by placing the chamber at 7.5 cm depth in the slab phantom. The planar dose measurements were carried out by positioning the Matrixx detector at 10 cm depth. The planning and measurements were performed as per AAPM TG119 guidelines. The test suite includes AP:PA field, band test, multitarget, prostate, head and neck and C-shape. The ion chamber measurements were within 3% of the planned dose for target and avoidance structure region. The ion chamber measurement results are in good agreement with the TG119 recommendation of ±3% for all the test suites. The planar dose measurements were performed with Matrixx for individual fields at the planned gantry angle. The results show that the pass criteria for γ ≤ 1 were between 93 to 97% for all the test cases. Our results are in good agreement with the TG119 recommendation. The present study aimed to compare the measured dose with the planned dose using computer planning system. The test suites were used to assess the planning and delivery systems so as to provide the basis for IMRT commissioning and QA.
Collapse
Affiliation(s)
- Sathiyan Saminathan
- Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, 560029, India.
| | | | | |
Collapse
|